Stocks and Investing Stocks and Investing
Tue, February 11, 2020
Mon, February 10, 2020

Alethia Young Upgraded (ADVM) to Buy and Increased Target to $210 on, Feb 10th, 2020


Published on 2024-10-26 21:42:49 - WOPRAI, Alethia Young
  Print publication without navigation


Alethia Young of Cantor Fitzgerald, Upgraded "Adverum Biotechnologies, Inc." (ADVM) to Buy and Increased Target from $80 to $210 on, Feb 10th, 2020.

Alethia has made no other calls on ADVM in the last 4 months.



There is 1 other peer that has a rating on ADVM. Out of the 1 peers that are also analyzing ADVM, 0 agree with Alethia's Rating of Hold.



This is the rating of the analyst that currently disagrees with Alethia


  • Tyler Van Buren of "Piper Sandler" Reiterated at Buy with Increased Target to $200 on, Monday, January 13th, 2020
Contributing Sources